Please login to the form below

Not currently logged in
Email:
Password:

M3 recruits Google’s former industry head of healthcare

Jenny Cowderoy joins online group's newly-expanded European operations

Jenny Cowderoy Google's former industry head of healthcare has joined M3 as the company expands in Europe, where its existing interests including the online physician network Doctors.net.uk.

Jenny Cowderoy, who also has direct pharma industry experience at GlaxoSmithKline (GSK), has been recruited as manager director of communications for the newly-launched M3 Europe.

Prior to her time at Google, where Cowderoy was responsible for business strategy and sales growth,  she spent time at GSK as director of global marketing, acting as a digital strategy adviser to the executive and global marketing teams.

M3 Europe will be led by CEO Dr Tim Ringrose, who will continue to serve in that role at M3's online doctor community Doctors.net.uk.

Commenting on Cowderoy's appointment he said: ”We are delighted to welcome Jenny to M3. She is a highly experienced and influential marketer, who has helped a wealth of multi-national healthcare companies to drive innovation and growth across their businesses through digital communication.

“Her considerable experience and expertise will help healthcare businesses across Europe to realise the benefits that digital marketing can bring.”

US-based M3 acquired Doctors.net.uk in August 2011 and claims a leadership position in online doctor networks with reach of more than 2.5 million physicians in Asia, US, Europe and emerging markets.

Its new European division will operate Doctors.net.uk, MDLinx (Europe), Networks in Health, medeConnect and the M3 Global Research Panel.


26th March 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
integrated medhealth communication

imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...